Expression and characterization of recombinant human micro-plasminogen

Biotechnology Letters

Volumn 29, Issue 4, 2007, Pages 517-523

  Ma, Zhifeng ^a   Lu, Wei ^a   Wu, Sheng ^a   Chen, Junyong ^a   Sun, Ziyong ^a   Liu, Jian Ning ^a  

^a NANJING UNIVERSITY   (China)

Author keywords

Expression; Micro plasminogen; Prourokinase; Purification; Urokinase

Indexed keywords

AMIDOLYTIC ACTIVITY; MICROPLASMINOGEN; PLASMIN ACTIVATION; UROKINASES;

BLOOD; CELLS; ESCHERICHIA COLI; GENES; PURIFICATION;

ENZYMES;

MICROPLASMINOGEN PROTEIN, HUMAN; PEPTIDE FRAGMENT; PLASMINOGEN; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG; UROKINASE;

ARTICLE; CATALYSIS; CHEMISTRY; ESCHERICHIA COLI; GENETICS; HUMAN; METABOLISM; METHODOLOGY; PROTEIN ENGINEERING;

CATALYSIS; ESCHERICHIA COLI; HUMANS; PEPTIDE FRAGMENTS; PLASMINOGEN; PROTEIN ENGINEERING; RECOMBINANT PROTEINS; URINARY PLASMINOGEN ACTIVATOR;

ESCHERICHIA COLI;

EID: 33847722615     PISSN: 01415492     EISSN: 15736776     Source Type: Journal    
DOI: 10.1007/s10529-006-9290-5     Document Type: Article

References (18)

1. An SS, Carreno C, Marti DN et al. (1998) Lysine-50 is a likely site for anchoring the plasminogen N-terminal peptide to lysine-binding kringles. Protein Sci 7:1960-1969
2. Beckmann R, Geiger M, Binder BR et al. (1988) Plasminogen activation by tissue plasminogen activator in the presence of stimulating CNBr fragment FCB-2 of fibrinogen is a two-phase reaction. Kinetic analysis of the initial phase of slow plasmin formation. J Biol Chem 263:7176-7180
3. Castellino FJ, Powell JR (1981) Human plasminogen. Meth Enzymol 80:365-378
4. Cockell CS, Marshall JM, Dawson KM et al. (1998) Evidence that the conformation of unliganded human plasminogen is maintained via an intramolecular interaction between the lysine-binding site of kringle 5 and the N-terminal peptide. Biochem J 333:99-105
5. Gunzler VA, Steffens GJ, Otting F et al. (1982) Structural relationship between human high and low molecular mass urokinase. Hoppe-Seyler's Z Physiol Chem 363:133-141
6. Horrevoets AJ, Smilde AE, Fredenburgh JC et al. (1995) The activation-resistant conformation of recombinant human plasminogen is stabilized by basic residues in the amino-terminal hinge region. J Biol Chem 270:15770-15776
7. Lapchak PA, Araujo DM, Pakola S et al. (2002) Microplasmin: a noval thrombolytic that improves behavioral outcome after embolic strokes in rabbits. Stroke 33:2279-2284
8. Lenich C, Pannell R, Gurewich V (1991) The effect of the carboxy-terminal lysine of urokinase on the catalysis of plasminogen activation. Thrombos Res 64:69-80
9. Liu JN, Gurewich V (1993) The kinetics of plasminogen activation by thrombin-cleaved pro-urokinase and promotion of its activity by fibrin fragment E-2 and by tissue plasminogen activator. Blood 81:980-987
10. Nagai N, Demarsin E, Van Hoef B et al. (2003) Recombinant human microplasmin: production and potential therapeutic properties. J Thromb Haemost 1:307-313
11. Pannell R, Black J, Gurewich V (1988) Complementary modes of action of tissue-type plasminogen activator and pro-urokinase by which their synergistic effect on clot lysis may be explained. J Clin Invest 81:853-859
12. Peltz SW, Hardt TA, Mangel WF et al. (1982) Positive regulation of activation of plasminogen by urokinase: differences in Km for (glutamic acid)-plasminogen and lysine-plasminogen and effect of certain alpha, omega-amino acids. Biochemistry 21:2798-2804
13. Qu J, Li X, Huang B (2005) Production of recombinant human microplasminogen and pilot study in inducing posterior vitreous detachment. Curr Eye Res 30:881- 889
14. Shi GY, Wu HL (1988) Isolation and characterization of microplasminogen. A low molecular weight form of plasminogen. J Biol Chem 263:17071-17075
15. Sun ZY, Chen YH, Wang P et al. (2002) The blockage of the high-affinity lysine binding sites of plasminogen by EACA significantly inhibits prourokinase-induced plasminogen activation. Biochim Biophys Acta 1596:182-192
16. Suzuki Y, Nagai N, Collen D (2004a) Comparative effects of microplasmin and tissue-type plasminogen activator (tPA) on cerebral hemorrhage in a middle cerebral artery occlusion model in mice. J Thromb Haemost 2:1617-1621
17. Suzuki Y, Chen F, Ni Y et al. (2004b) Microplasmin reduces ischemic brain damage and improves neurological function in a rat stroke model monitored with MRI. Stroke 35:2402-2406
18. Whitefleet-Smith J, Rosen E, Mclinden J et al. (1989) Expression of human plasminogen cDNA in a baculovirus vector-infected insect cell system. Arch Biochem Biophys 271:390-399